No profile data available.
Seres Therapeutics, Inc. (MCRB) is a healthcare company in the antibacterial pharmaceuticals industry, based in Cambridge, United States, with about 66 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of $136,000. In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $27.22 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a clinical-stage company, focuses on developing biotherapeutics for serious diseases.
Seres Therapeutics reported $0 in revenue for fiscal year 2024. In Q3 2025 revenue was $0.
$27.22 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antibacterial pharmaceuticals) include Spero Therapeutics, Inc. (SPRO), China Pharma Holdings, Inc. (CPHI), Evaxion A/S (EVAX), Acurx Pharmaceuticals, Inc. (ACXP).